Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
78 hedge funds and large institutions have $92.8M invested in Ampio Pharmaceuticals Inc. in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 4 closing their positions.
475% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
32% more funds holding
Funds holding: 59 → 78 (+19)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less capital invested
Capital invested by funds: $97.6M → $92.8M (-$4.86M)
61% less call options, than puts
Call options by funds: $1.39M | Put options by funds: $3.56M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$9.46M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$7.39M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.56M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.25M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$27.9M |
| 2 |
KeyBank National Association
Cleveland,
Ohio
|
-$1.5M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$762K |
| 4 |
TC
Talkot Capital
Sausalito,
California
|
-$664K |
| 5 |
LPL Financial
San Diego,
California
|
-$586K |
AMPE Hedge Fund Activity: Q1 2014 in Review
78 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2014, worth a combined $92.8M — down 5% from $97.6M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AMPE positions and 4 closed out — a net gain of 19 holders — while 26 added to existing stakes and 13 trimmed.
The largest buyer was DAFNA Capital Management, adding an estimated $9.46M. The largest seller was Noven Financial Group, cutting an estimated $27.9M.
- 78 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2014, up from 59 in Q4 2013.
- Funds reported $92.8M of Ampio Pharmaceuticals Inc. stock for Q1 2014, down 5% quarter-over-quarter.
- 23 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2014 and 4 closed out, a net change of +19 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2014 was DAFNA Capital Management, an estimated $9.46M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2014 was Noven Financial Group, an estimated $27.9M sold.
Based on aggregated 13F filings for Q1 2014.